FDA Approves Cook Medical’s Zenith Dissection Endovascular System


February 4, 2019—Cook Medical announced FDA approval of its Zenith dissection endovascular system.

The system includes a proximal stent graft component and a distal bare-metal stent component to provide a less invasive alternative to open surgery for repair of type B dissections of the descending thoracic aorta.

Cook noted that the device will be available for sale in the United States within the coming months.

“We’re pleased to provide another minimally invasive option for aortic repair,” said Mark Breedlove, Vice President of Cook Medical’s Vascular division, in the company's announcement. “The approval of this product gives us an opportunity to have a positive impact on the lives of patients with aortic dissections.”


Contact Info

For advertising rates and opportunities, contact:
Craig McChesney

Stephen Hoerst

Charles Philip

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.